A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin
- 31 December 1995
- journal article
- case report
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (4), 606-611
- https://doi.org/10.1016/0959-8049(95)00048-n
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosisMedical and Pediatric Oncology, 1993
- Overview of Current Treatment of NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992
- Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen)British Journal of Cancer, 1990
- 131I-Metaiodobenzylguanidine in the Treatment of Neuroblastoma at DiagnosisJournal of Pediatric Hematology/Oncology, 1989
- A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique.Journal of Clinical Oncology, 1987
- Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical dataInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Treatment of neuroblastoma with 131I‐MIBG: Dosimetric problems and perspectivesMedical and Pediatric Oncology, 1987
- Treatment of neuroblastoma with131I-metaiodobenzylguanidineMedical and Pediatric Oncology, 1987
- Editorial: The treatment of neuroblastoma with131I-MIBGMedical and Pediatric Oncology, 1987
- Carboplatin as a potentiator of radiation therapyCancer Treatment Reviews, 1985